Department of Chemistry, Vivekanand College, Shivaji University, Kolhapur, India.
J Sep Sci. 2023 Jul;46(13):e2201067. doi: 10.1002/jssc.202201067. Epub 2023 Apr 14.
The (E)-isomer of rilpivirine is an approved antiretroviral drug used to treat human immunodeficiency virus. A simple, fast, accurate, and precise analytical method is required to confirm the quality, purity, efficacy, and safety of drug substances and drug products containing rilpivirine. This research article offers a comprehensive ultra-high performance liquid chromatography method for the simultaneous separation and quantification of (E) and (Z) isomers of rilpivirine, including two amide impurities, one nitrile impurity, and one dimer impurity, in both bulk and tablet forms. After complete validation, the proposed reversed-phase ultra-high-performance liquid chromatography method has proven to be simple, fast, linear, accurate, and precise, with a lower limit of quantification and detection of 0.05 and 0.03 μg/ml, respectively, for all six analytes. Separation was achieved on a Waters Acquity ethylene bridged hybrid Shield RP18 (150 × 2.1 mm, 1.7 μm) column maintained at 35.0°C using a gradient elution of acetonitrile and 0.05% formic acid in 10 mM ammonium formate at a flow rate of 0.30 ml/min. A systematic forced degradation study on the undissolved rilpivirine revealed the formation of acid-base hydrolyzed amide impurities (Impurity-A and Impurity-B), oxidative nitrile impurities (Impurity-C), and Z-isomer and dimer impurities of rilpivirine (Impurity-D and Impurity-E) due to alkaline hydrolysis and photodegradation. The proposed method is primarily appropriate for applications requiring the precise determination of desired and undesired isomers of rilpivirine and its degradation products, such as those involving the safety, efficacy, and quality roles of rilpivirine in bulk and tablet forms. Additionally, the proposed ultra-high-performance liquid chromatography method in combination with a mass spectrometer and photo-diode array detector is helpful for the confirmation and correct identification of all analytes.
依匹韦林的(E)-异构体是一种已批准的抗逆转录病毒药物,用于治疗人类免疫缺陷病毒。需要一种简单、快速、准确和精密的分析方法来确认含有依匹韦林的药物物质和药物产品的质量、纯度、功效和安全性。本文提供了一种全面的超高效液相色谱法,用于同时分离和定量依匹韦林的(E)和(Z)异构体,包括两种酰胺杂质、一种腈杂质和一种二聚体杂质,无论是在散装形式还是片剂形式。经过全面验证,所提出的反相超高效液相色谱法已被证明是简单、快速、线性、准确和精密的,对于所有六种分析物,定量下限和检测下限分别为 0.05 和 0.03μg/ml。分离是在 Waters Acquity 乙烯桥合混合 Shield RP18(150×2.1mm,1.7μm)柱上实现的,柱温为 35.0°C,采用乙腈和 0.05%甲酸在 10mM 甲酸铵中的梯度洗脱,流速为 0.30ml/min。对未溶解的依匹韦林进行的系统强制降解研究表明,由于碱性水解和光降解,形成了酸碱水解酰胺杂质(杂质 A 和杂质 B)、氧化腈杂质(杂质 C)以及依匹韦林的 Z-异构体和二聚体杂质(杂质 D 和杂质 E)。该方法主要适用于需要精确测定依匹韦林及其降解产物的所需和不需要异构体的应用,例如涉及依匹韦林在散装和片剂形式中的安全性、功效和质量作用的应用。此外,结合质谱仪和光电二极管阵列检测器的提议的超高效液相色谱法有助于对所有分析物进行确认和正确识别。